Fabiana Letizia Cecere

Istituti di Ricovero e Cura a Carattere Scientifico

Papers

2

Total Citations

43

H-Index

2

About

Fabiana Letizia Cecere is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for early-stage non-small cell lung cancer (NSCLC). Her major contributions center on evaluating the oncological efficacy of robotic-assisted lobectomy compared to traditional approaches. In her highly cited 2021 study (28 citations), Cecere demonstrated that robotic-assisted lobectomy achieves comparable nodal upstaging to video-assisted thoracic surgery and thoracotomy, challenging assumptions about the completeness of lymphadenectomy in minimally invasive procedures. Her subsequent 2022 work (15 citations) further validated robotic lobectomy by reporting favorable oncological outcomes, including survival and recurrence rates, for early-stage NSCLC patients. These findings have helped establish robotic surgery as a viable, less invasive alternative to thoracotomy without compromising cancer clearance. Through rigorous retrospective analyses, Cecere has provided crucial evidence supporting the integration of robotic platforms into standard thoracic oncology practice. Her work continues to shape surgical decision-making, offering patients improved peri-operative recovery while maintaining rigorous oncologic standards.

Research Focus

Key Achievements

2
H-Index
2
Papers
43
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Nodal Upstaging Evaluation After Robotic-Assisted Lobectomy for Early-Stage Non-small Cell Lung Cancer Compared to Video-Assisted Thoracic Surgery and Thoracotomy: A Retrospective Single Center Analysis
28 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Istituti di Ricovero e Cura a Carattere Scientifico

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago